期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

活体光学成像技术在眼科学领域的应用前景 被引量：2

Prospect of in vivo optic imaging in ophthalmology
下载PDF
导出
摘要 活体光学成像技术是一种可实时动态观察生物生物学行为的影像学技术,目前已经应用于生命科学的各个方面,如干细胞治疗、肿瘤研究和药物研究等。该技术在眼科学领域也有很大的应用潜力。现对活体光学成像技术的应用现状作一总结,并展望其在眼科学领域的应用前景。 In vivo optic imaging is a newly developing technology that could observe biological behavior dynamically,and was put into use of various aspects of life science,such as stem cell therapy,cancer research,drug research and so on.The technology also has the potential in ophthalmology.This article reviews the application and prospect of in vivo optic imaging in ophthalmology.
作者 李鹤一 王雨生
机构地区 第四军医大学西京医院眼科全军眼科研究所
出处 《眼科新进展》 CAS 北大核心 2011年第6期501-503,共3页 Recent Advances in Ophthalmology
关键词 活体光学成像技术 眼科学 干细胞治疗 in vivo optic imaging ophthalmology stem cell therapy
分类号 R778 [医药卫生—眼科]
  • 相关文献

参考文献15

  • 1Choy G, Choyke P, Libutti SK. Current advances in molecular imaging: noninvasive in vivo bioluminescent and fluorescent optical imaging in cancer research [ J ]. Mol Imaging, 2003,2 (4) :303-312.
  • 2Hoffman RM. The multiple uses of fluorescent proteins to visualize cancer in vivo [ J ]. Nat Rev Cancer,2005,5 ( 10 ) : 795-805.
  • 3Hou HY, Liang HL, Wang YS, Zhang ZX, Wang BR, Shi YY, et al. A novel therapeutic strategy for choroidal neovascularization based on the recruitment of mesenchymal stem cells to the sites of lesion[ J]. Mol Ther,2010,18 (10) : 1837-1845.
  • 4Weissleder R, Pittet MJ. Imaging in the era of molecular oncologY[ J ] . Nature,2008,452 (7187) :580-589.
  • 5李慧,戴汝为.在体生物光学成像技术的研究进展[J].自动化学报,2008,34(12):1449-1457. 被引量：8
  • 6Jey Cheng,Keith Wood,Frank Fan.生物发光技术在生命科学中的应用[J].生物物理学报,2009,25(5):356-360. 被引量：3
  • 7Srinivas M, Aarntzen EH, Bulte JW, Oyen W J, Heerschap A, de Vries I J, et al. Imaging of cellular therapies [ J ]. Adv Drug Deliv Rev ,2010,62 (11 ) : 1080-1093.
  • 8Van der Bogt KE, Schrepfer S, Yu J, Sheikh AY, Hoyt G, Govaert JA, et al. Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart [ J ]. Transplantation,2009,87 (5) :542-652.
  • 9Wetterwald A,Van der Pluijm G,Que I,Sijmons B,Buijs J,Karperien M, et al. Optical ima~ng of cancer metastasis to bone marrow: a mouse model of minimal residual disease [ J ]. Am J Pathol,2002,160 ( 3 ) : 1143-1153.
  • 10Feng B, Tomizawa K, Michiue H, Han XJ, Miyatake S, Matsui H. Development of a bifunctional immunoliposome system for com- bined drug delivery and imaging in vivo [ J ]. Biomaterials, 2010,31 (14) :4139-4145.

二级参考文献7

  • 1李慧,田捷,王革.基于Monte Carlo在体生物光学成像的光子传输模型[J].软件学报,2004,15(11):1709-1719. 被引量：6
  • 2LI Hui,TIAN Jie,LUO Jie,LUE Yujie,CONG Wenxiang,WANG Ge.Design and implementation of an optical simulation environment for bioluminescent tomography studies[J].Progress in Natural Science:Materials International,2007,17(1):87-94. 被引量：1
  • 3O'Brien MA, Daily WJ, Hesselberth PE, Moravec RA, Scurria MA, Klaubert DH, Bulleit RF, Wood KV. Homogeneous, bioluminescent protease assays: caspase-3 as a model. J Biomol Screen, 2005,10(2):137-148.
  • 4Cali JJ, Ma D, Sobol M, Simpson DJ, Frackman S, Good TD, Daily WJ, Liu D. Luminogenic cytochrome P450 assays. Expert Opin Drug Metab Toxicol, 2006,2(4):629-645.
  • 5Fan F, Wood KV. Bioluminescent assays for high-throughput screening. Assay Drug Dev Technol, 2007,5(1):127-136.
  • 6Riss TL, Moravec RA. Use of multiple assay endpoints to investigate the effects of incubation time, dose of toxin, and plating density in cell-based cytotoxicity assays. Assay Drug Dev Technol, 2004,2(1):51-62.
  • 7Kumar M, Hsiao K, bioluminescent-based, Vidugiriene J, Goueli SA. A HTS-compatible assay to monitor G-protein-coupled receptor modulation of cellular cyclic AMP. Assay Drug Dev Technol, 2007,5(2):237-245.

共引文献9

同被引文献29

  • 1杨秀梅,王雨生.脉络膜新生血管的动物模型[J].国际眼科纵览,2006,30(3):166-170. 被引量：18
  • 2Fine SL. Age-related macular degeneration 1969-2004: a 35-yearpersonal perspective[ J]. Am J Ophthalmol,2005,139 (3 ) :405-420.
  • 3Leconito J,Louis K,Detry B, Blacher S,Lambert V,Bekaerlal. Bom' inarrow-derived mesenchymal cells and MMPI3 con-tribute to experimental choroidal neovascularization [ J ]. CellMol Life Sri’2011 ,68(4) :677-686.
  • 4Hou IIY.Liaiig HL.Wang YS. Bone marrow-derived cells in i\eo-vascular age-related macular degeneration : contribution and po-tential application[ J]. Ophthalmic Res,2011 ,45( 1): 14.
  • 5Hou irV.Wang YS, Xu JF, Waiig YC, Uu JP. The dynamic con-duct of bone marrow-derived cells in the choroidal neovascular-ization microenviromentf J ]. Ourr Eye Res, 2006,31 ( 12) : 1051 -1061.
  • 6Espinosa-1leidmaim DG, Caicedo A, Hernandez EP, Csaky KG,Cousins SW. Bone marrow-derived progenitor cells contribute toexperimental choroidal neovascularization [J]. Invest Ophthal-mol Vis Sci,2003 ,44(11) :4914-49I9.
  • 7Espinosa-Heidmann DG,Caicedo A,Hernandez EP,Csaky KG,Cousins SW. Bone marrow- derived progenitor cells contribute toexperimental choroidal neovascularization [ J ]. Invest Ophthal-mol Vis Sci,2003,44( 11) :4914^919.
  • 8Close DM,Xu T,Sayler GS,Ripp S. In vivo bioluminescent ima-ging ( BLI) : noninvasive visualization and interrogation of biolog-ical processes in living animals [J]. Sensors (Basel),2011,11(1):180-206.
  • 9Li Z,Lee A,Huang M, Chun H, Chung J, Chu P,et al. Imagingsurvival and function of transplanted cardiac resident stem cells[i].JAm CoU Cardiol,2009f53( 14) : 1229-1240.
  • 10Li Z, Wu JC,Sheikh AY,Kraft D,Cao F,Xie X,et al. Differentia-tion ,survival,and function of embryonic stem cell derived endo-thelial cells for ischemic heart disease[ J]. Circulation,2007,116(11 Suppl) :146-154.

引证文献2

二级引证文献2

眼科新进展
2011年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部